510(k) Report

510(k) · Decided

Decided

Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and Delivery System

K024303510(k) TraditionalDecided Jul 3, 2003191-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Edwards Lifesciences, LLC · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Jul 3, 2003 as substantially equivalent to K001843 (Cordis Corp., 2000) and 3 other predicates after a 191-day review. Its family tree reaches back 3 generations to 2001. 4 later devices descend from it.

Decided
Jul 3, 2003
Review
191 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
4

Its longest line of descent runs back 3 generations to K010445 (2001). 6 ancestors in all, the oldest K971010 (1997). 4 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2000: 1 other ancestor2001: 1 other ancestor1997: 1 other ancestor2005: 1 descendant cleared2004: 1 descendant cleared2006: 1 descendant cleared2013: 1 descendant clearedK010445 · Precise Nitinol Stent Transhepatic Billary System · Cordis Corp. · 2001K012993 · Modification to Precise Nitinol Stent Transhepatic Biliary System · Cordis Corp. · 2001 · recalledK021898 · Smart Control Nitinol Stent Transhepatic Biliary System · Cordis Corp. · 2002 · recalled1995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 2 other ancestors 1 generation forward: 2 descendants2 generations forward: 2 descendants K021898 · Smart Control Nitinol Stent Transhepatic Biliary System · Cordis Corp. · 2002 · recalledK012993 · Modification to Precise Nitinol Stent Transhepatic Biliary System · Cordis Corp. · 2001 · recalledK010445 · Precise Nitinol Stent Transhepatic Billary System · Cordis Corp. · 20010
  1. Root · 3 generations backK010445 Precise Nitinol Stent Transhepatic Billary SystemCordis Corp. · 2001
  2. 2 generations backK012993 Modification to Precise Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2001 · Recalled
  3. 1 generation backK021898 Smart Control Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2002 · Recalled
  4. This deviceK024303 Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and…Edwards Lifesciences, LLC · 2003
  5. Descendant · cites it directly · 3 of its ownK042985 Lifestent NT35 Biliary Stent SystemEdwards Lifesciences, LLC · 2004
  6. Descendant · cites it directly · 2 of its ownK053404 Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC · 2005 · Recalled
  7. Descendant · 2 generations on · 1 of its ownK060487 Lifestent Flexstar XL Biliary Stent SystemEdwards Lifesciences, LLC · 2006
  8. Descendant · 2 generations on · 0 of its ownK130792 Lifestent Biliary Stent System, Lifestent XL Biliary Stent SystemC.R. Bard, Inc. · 2013

Most influential descendants

Showing 4 of 4 · See all
  • K042985Lifestent NT35 Biliary Stent SystemEdwards Lifesciences, LLC · 2004 · cites it directly3descendants
  • K053404Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC · 2005 · cites it directly2descendants
  • K060487Lifestent Flexstar XL Biliary Stent SystemEdwards Lifesciences, LLC · 2006 · 2 generations on1descendant
  • K130792Lifestent Biliary Stent System, Lifestent XL Biliary Stent SystemC.R. Bard, Inc. · 2013 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K010445Precise Nitinol Stent Transhepatic Billary SystemCordis Corp.2001—
−2K012993Modification to Precise Nitinol Stent Transhepatic Biliary SystemCordis Corp.20011
−1K021898Smart Control Nitinol Stent Transhepatic Biliary SystemCordis Corp.20021
0 (this device)K024303Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and Delivery…Edwards Lifesciences, LLC2003—
+1K042985Lifestent NT35 Biliary Stent SystemEdwards Lifesciences, LLC2004—
+1K053404Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC2005103
+2K060487Lifestent Flexstar XL Biliary Stent SystemEdwards Lifesciences, LLC2006—
+2K130792Lifestent Biliary Stent System, Lifestent XL Biliary Stent SystemC.R. Bard, Inc.2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
200010
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200510
200610
201310
FIG. 1 — Lineage of K024303, 2001–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K001843S.M.a.R.T. Nitinol Stent Transhepatic Biliary System
Summary page 1
…(self-expanding) 6. Device Classification Name: Biliary Catheter (78 FGE), Class |l 7. Predicate Devices: Cordis S.M.A.R.T.™ Nitinol Stent Transhepatic Biliary System (K001843) Cordis Precise™ Nitinol Stent Transhepatic Biliary System (K010445) Cordis Precise™ Nitinol Stent Transhepatic Biliary System…
Cordis Corp.2000—
*K010445Precise Nitinol Stent Transhepatic Billary System
Summary page 1
…FGE), Class |l 7. Predicate Devices: Cordis S.M.A.R.T.™ Nitinol Stent Transhepatic Biliary System (K001843) Cordis Precise™ Nitinol Stent Transhepatic Biliary System (K010445) Cordis Precise™ Nitinol Stent Transhepatic Biliary System (6F) (K012993) Cordis S.M.A.R.T.™ Control™ Nitinol Stent Transhepati…
Cordis Corp.2001—
*K012993Modification to Precise Nitinol Stent Transhepatic Biliary System
Summary page 1
…anshepatic Biliary System (K001843) Cordis Precise™ Nitinol Stent Transhepatic Biliary System (K010445) Cordis Precise™ Nitinol Stent Transhepatic Biliary System (6F) (K012993) Cordis S.M.A.R.T.™ Control™ Nitinol Stent Transhepatic Biliary System (K021898) Edwards Lifesciences LLC One Edwards Way - Irv…
Cordis Corp.20011
*K021898Smart Control Nitinol Stent Transhepatic Biliary System
Summary page 1
…iliary System (K010445) Cordis Precise™ Nitinol Stent Transhepatic Biliary System (6F) (K012993) Cordis S.M.A.R.T.™ Control™ Nitinol Stent Transhepatic Biliary System (K021898) Edwards Lifesciences LLC One Edwards Way - Irvine, CA USA - 92614 Phone: 949.250.2500 - Fa§§4§.250.2525 - www.edwards.com Kox4…
Cordis Corp.20021

Also cleared against K001843: 4 other devices →

What descends from it? (4)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042985Lifestent NT35 Biliary Stent SystemEdwards Lifesciences, LLC20043
K053404Lifestent Flexstart Biliary Stent SystemEdwards Lifesciences, LLC20052

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 2 years and passes through 2 companies; a new generation was cleared every 10 months on median.
  • 2 of the 6 ancestors have a recall of any class.
  • Of its descendants, K042985 (Edwards Lifesciences, LLC, 2004) has gone furthest, with 3 descendants of its own.
  • 4 other devices also cite its predicate K001843.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

The Edwards Lifesciences LifeStent NTl8 Self-Expanding Biliary Stent and Delivery System is indicated for use in the palliative treatment of patients with malignant biliary strictures.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K024303: Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and Delivery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K024303

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026